The store will not work correctly when cookies are disabled.
N'-(2-Hydroxybenzoyl)-8-methoxy-2-oxo-2H-chromene-3-carbohydrazide
ID: ALA4578898
PubChem CID: 145999287
Max Phase: Preclinical
Molecular Formula: C18H14N2O6
Molecular Weight: 354.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc2cc(C(=O)NNC(=O)c3ccccc3O)c(=O)oc12
Standard InChI: InChI=1S/C18H14N2O6/c1-25-14-8-4-5-10-9-12(18(24)26-15(10)14)17(23)20-19-16(22)11-6-2-3-7-13(11)21/h2-9,21H,1H3,(H,19,22)(H,20,23)
Standard InChI Key: JYGFVPYJQDFGLO-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.2496 -19.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2485 -20.1225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9565 -20.5315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9547 -18.8941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6634 -19.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6622 -20.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3723 -20.5359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0881 -20.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0893 -19.3015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3746 -18.8856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7947 -20.5372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7980 -18.8946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5047 -19.3049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8000 -18.0774 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2134 -18.8981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9201 -19.3084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6288 -18.9015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9181 -20.1256 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3319 -19.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0401 -18.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0426 -18.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3309 -17.6799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6256 -18.0885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3278 -20.1315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9562 -21.3487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2484 -21.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
19 24 1 0
3 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.32 | Molecular Weight (Monoisotopic): 354.0852 | AlogP: 1.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 117.87 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.05 | CX Basic pKa: ┄ | CX LogP: 2.02 | CX LogD: 1.93 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: -0.63 |
References
1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R.. (2019) Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors., 10 (1): [PMID:30774857] [10.1039/C8MD00328A] |